Profil
Michael C.
Thompson currently works at DICE Therapeutics, Inc., as Treasurer & Director from 2023, Sigilon Therapeutics, Inc., as Treasurer & Director from 2023, and POINT Biopharma Global, Inc., as Treasurer & Director from 2023.
Postes actifs de Michael Thompson
| Sociétés | Poste | Début |
|---|---|---|
| DICE THER | Director/Board Member | 09/08/2023 |
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 11/08/2023 |
| POIT BIOP | Director/Board Member | 27/12/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| POIT BIOP | Health Technology |
| Entreprise privées | 1 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
